These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


837 related items for PubMed ID: 11805567

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL.
    Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026
    [Abstract] [Full Text] [Related]

  • 23. [Colorectal cancer in patients with ulcerative colitis].
    Matsumoto T, Hida N.
    Nihon Shokakibyo Gakkai Zasshi; 2006 Jul 29; 103(7):805-11. PubMed ID: 16869381
    [No Abstract] [Full Text] [Related]

  • 24. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study.
    Kornfeld D, Ekbom A, Ihre T.
    Gut; 1997 Oct 29; 41(4):522-5. PubMed ID: 9391253
    [Abstract] [Full Text] [Related]

  • 25. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?
    Jayaram H, Satsangi J, Chapman RW.
    Gut; 2001 Mar 29; 48(3):430-4. PubMed ID: 11171838
    [No Abstract] [Full Text] [Related]

  • 26. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.
    Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A.
    Gastroenterology; 2004 Feb 29; 126(2):451-9. PubMed ID: 14762782
    [Abstract] [Full Text] [Related]

  • 27. Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy?
    Broomé U, Lindberg G, Löfberg R.
    Gastroenterology; 1992 Jun 29; 102(6):1877-80. PubMed ID: 1587406
    [Abstract] [Full Text] [Related]

  • 28. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J, Stenling R, Palmqvist R, Rutegård J.
    J Pediatr Gastroenterol Nutr; 2008 May 29; 46(5):534-8. PubMed ID: 18493208
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Multifocal colorectal cancer in ulcerative colitis patient with sclerosing cholangitis - case report.
    Kosmowska A, Krokowicz P, Nelke M.
    Pol Przegl Chir; 2020 Feb 12; 92(5):1-5. PubMed ID: 32945783
    [Abstract] [Full Text] [Related]

  • 32. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R, Lauwers GY, Choi WT.
    J Crohns Colitis; 2022 Dec 05; 16(12):1825-1834. PubMed ID: 35771958
    [Abstract] [Full Text] [Related]

  • 33. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis.
    Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ.
    Gastroenterology; 1996 Feb 05; 110(2):432-40. PubMed ID: 8566590
    [Abstract] [Full Text] [Related]

  • 34. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR, Lashner BA, Hanauer SB.
    Am J Gastroenterol; 1993 Aug 05; 88(8):1174-8. PubMed ID: 8338083
    [Abstract] [Full Text] [Related]

  • 35. Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study.
    Ståhlberg D, Veress B, Tribukait B, Broomé U.
    Dis Colon Rectum; 2003 Jun 05; 46(6):770-8. PubMed ID: 12794579
    [Abstract] [Full Text] [Related]

  • 36. Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis.
    Seo M, Okada M, Osamura S, Hara S, Umeno T, Maeshiro K, Yamada Y, Yuh K.
    J Gastroenterol; 1997 Feb 05; 32(1):83-8. PubMed ID: 9058300
    [Abstract] [Full Text] [Related]

  • 37. Most dysplasia in ulcerative colitis is visible at colonoscopy.
    Rutter MD, Saunders BP, Wilkinson KH, Kamm MA, Williams CB, Forbes A.
    Gastrointest Endosc; 2004 Sep 05; 60(3):334-9. PubMed ID: 15332019
    [Abstract] [Full Text] [Related]

  • 38. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
    Goldstone R, Itzkowitz S, Harpaz N, Ullman T.
    Inflamm Bowel Dis; 2012 May 05; 18(5):832-7. PubMed ID: 21739534
    [Abstract] [Full Text] [Related]

  • 39. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Lindor KD.
    Am J Gastroenterol; 2011 Sep 05; 106(9):1638-45. PubMed ID: 21556038
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R, Sambuelli A, Coronel E, Mazzuco J, Cartier M, Negreira S, Muñoz A, Gil A, Miguez C, Huernos S, Romero G, Goncalvez S, Levi D, Abecasis R.
    Acta Gastroenterol Latinoam; 2008 Mar 05; 38(1):26-33. PubMed ID: 18533354
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 42.